 |
|
Prevention of Malaria in Long-term Travelers
Lin H. Chen, MD;
Mary E. Wilson, MD;
Patricia Schlagenhauf, PhD
JAMA. 2006;296:2234-2244.
Context Long-term travelers, defined here as those traveling for periods of 6 months or longer, face particular challenges regarding malaria prevention. Current guidelines for malaria prevention primarily address prevention of Plasmodium falciparum infections in short-term travelers.
Objectives To examine the risk of malaria in long-term travelers, recent developments in personal protective measures, and the safety and tolerability of malaria chemoprophylaxis during long-term use and to consider prevention strategies including continuous chemoprophylaxis, stand-by emergency self-treatment, seasonal prophylaxis, and strategies to prevent primary infection and relapses from P vivax malaria.
Evidence Acquisition Comprehensive search of scientific publications including MEDLINE via both OVID and PubMED for relevant studies and articles with a cutoff date of July 2006, using the search terms long-term travel and malaria prevention, long-term malaria chemoprophylaxis, and insect repellent and malaria. Additional references were obtained from searching the bibliographies of the selected articles, from dissertations, and from the proceedings of relevant conferences on travel medicine. There were no language restrictions.
Evidence Synthesis Long-term travelers have a higher risk of malaria than short-term travelers. Long-term travelers underuse personal protective measures and adhere poorly to continuous chemoprophylaxis regimens. A number of strategies are used during long-term stays: discontinuation of chemoprophylaxis after the initial period, sequential regimens with different medications for chemoprophylaxis, stand-by emergency self-treatment, and seasonal chemoprophylaxis targeting high-incidence periods or locations. All strategies have advantages and drawbacks. Counterfeit drugs sold in countries endemic for malaria pose serious concern for long-term travelers who purchase their medications overseas. Vivax malaria causes significant illness in travelers, but relapses of vivax malaria are not prevented with the current first-line chemoprophylaxis regimens. Consensus guidelines are needed for prevention of malaria in long-term travelers.
Conclusions Prevention of malaria in long-term travelers is a complex issue and requires expert advice from travel medicine specialists. Recommendations for prevention of malaria in long-term travelers must be individualized.
Author Affiliations: Mount Auburn Hospital, Cambridge, Mass (Drs Chen and Wilson); Harvard Medical School (Drs Chen and Wilson) and Harvard School of Public Health (Dr Wilson), Boston, Mass; and University of Zürich, World Health Organization Collaborative Center for Travelers' Health, Zürich, Switzerland (Dr Schlagenhauf).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Resurgence of Plasmodium vivax Malaria in the Republic of Korea during 2006-2007
Jun et al.
Am J Trop Med Hyg 2009;81:605-610.
ABSTRACT
| FULL TEXT
Malaria Prevention in Short-Term Travelers
Freedman
NEJM 2008;359:603-612.
FULL TEXT
Malaria Chemoprophylaxis: Strategies for Risk Groups
Schlagenhauf and Petersen
Clin. Microbiol. Rev. 2008;21:466-472.
ABSTRACT
| FULL TEXT
Clinical Malaria and Sickle Cell Disease Among Multiple Family Members in Chicago, Illinois
Glikman et al.
Pediatrics 2007;120:e745-e748.
ABSTRACT
| FULL TEXT
Controversies and Misconceptions in Malaria Chemoprophylaxis for Travelers
Chen et al.
JAMA 2007;297:2251-2263.
ABSTRACT
| FULL TEXT
|
